Urotensin II Polyclonal Antibody

UTS2 encodes a mature peptide that is an active cyclic heptapeptide absolutely conserved from lamprey to human. The active peptide acts as a vasoconstrictor and is expressed only in brain tissue. Despite the gene family name similarity, this gene is not homologous to urocortin, a member of the sauvagine/corticotropin-releasing factor/urotensin I family. Most of the proprotein is cleaved to make the mature peptide. Transcript variants encoding different preproprotein isoforms have been described for this gene.

Introducing the Urotensin II Polyclonal Antibody, a cutting-edge scientific tool meticulously designed to facilitate advanced research in the field of molecular biology. This highly specific antibody has been developed with utmost precision and expertise to target and detect Urotensin II, a potent vasoconstrictor peptide involved in various physiological processes.

Crafted using state-of-the-art techniques, this polyclonal antibody exhibits exceptional sensitivity and selectivity, enabling accurate and reliable detection of Urotensin II in a wide range of biological samples. Its superior affinity for the target molecule ensures optimal performance, allowing for precise quantification and localization studies.

The Urotensin II Polyclonal Antibody boasts an extensive range of applications, making it an indispensable tool for researchers in diverse scientific disciplines. From elucidating the role of Urotensin II in cardiovascular diseases to investigating its involvement in neurological disorders, this antibody offers unparalleled versatility and adaptability.

With its robust and reproducible results, this antibody guarantees consistent performance across multiple experiments, ensuring the reliability and validity of research findings. Its exceptional stability and long shelf life further enhance its value, providing researchers with a cost-effective solution for their ongoing investigations.

In addition to its exceptional scientific attributes, the Urotensin II Polyclonal Antibody is accompanied by comprehensive technical support, including detailed protocols and expert guidance. This ensures seamless integration into existing experimental workflows, facilitating efficient and successful research outcomes.

In summary, the Urotensin II Polyclonal Antibody represents a breakthrough in molecular biology research, offering unparalleled sensitivity, specificity, and versatility. With its exceptional performance, stability, and comprehensive technical support, this antibody is an indispensable asset for scientists striving to unravel the intricate mechanisms underlying Urotensin II-related phenomena.